NICOM brochure spreads F - Prhoinsa · 2015. 9. 18. · o) m!2)*gmn),;7g)agg2?m6p)m*g)!gg2g2c.# d...
5
Transcript of NICOM brochure spreads F - Prhoinsa · 2015. 9. 18. · o) m!2)*gmn),;7g)agg2?m6p)m*g)!gg2g2c.# d...
Cheetah NICOMNoninvasive Real Tim
e Hemodynam
ic Data for Real Tim
e Clinical Decision Making
No
ma
tter w
he
re th
e p
atie
nt is in
the
ho
spita
l or w
ha
t the
clin
ica
l ch
alle
ng
e, e
ffec
tive h
em
od
yna
mic
me
asu
rem
en
t an
d m
an
ag
em
en
t is inte
gra
l to a
ch
ievin
g a
n o
ptim
al c
linic
al o
utc
om
e. U
ntil n
ow
,
the
on
ly ch
oic
es fo
r ob
tain
ing
ac
cu
rate
, co
ntin
uo
us h
em
od
yna
mic
me
asu
rem
en
ts we
re in
vasive
tec
hn
olo
gie
s tha
t ca
rry the
ir ow
n se
t of risks.
With
the
Ch
ee
tah
NIC
OM
No
nin
vasive
He
mo
dyn
am
ic M
on
itor, th
e c
linic
ian
ha
s all th
e im
po
rtan
t
pa
ram
ete
rs co
ntin
uo
usly a
t his/h
er fin
ge
rtips. C
linic
al sta
tus a
nd
the
effe
ct o
f fluid
s ca
n b
e m
on
itore
d
at a
ny tim
e a
nd
trea
tme
nt m
od
ified
ac
co
rdin
gly.
Cheetah NICOM Technology
The
Ch
ee
tah
NIC
OM
’s un
iqu
e, p
ate
nte
d Bio
rea
cta
nc
e® te
ch
no
log
y take
s me
asu
rem
en
ts co
ntin
uo
usly
an
d p
rec
isely. A
nd
it req
uire
s on
ly fou
r sen
sors, e
asily p
lac
ed
on
the
ch
est. Th
e se
nso
rs ca
n b
e p
lac
ed
an
ywh
ere
on
the
ch
est o
r ba
ck a
s lon
g a
s two
are
po
sition
ed
ab
ove
an
d tw
o a
re p
ositio
ne
d b
elo
w
the
he
art.
An
ele
ctric
cu
rren
t of k
no
wn
freq
ue
nc
y is
ap
plie
d a
cro
ss
the
tho
rax b
etw
ee
n th
e o
ute
r
pa
ir of s
en
so
rs.
A s
ign
al is
rec
ord
ed
be
twe
en
the
inn
er p
air o
f se
nso
rs.
Th
e b
loo
d a
bso
rbs e
lec
tron
s,
ca
usin
g a
de
lay
in th
e s
ign
al.
Th
e d
ela
y is
pro
po
rtion
al to
the
vo
lum
e o
f blo
od
, an
d th
e
info
rma
tion
is u
pd
ate
d e
ve
ry
60 s
ec
on
ds.
Th
is tim
e d
ela
y, c
alle
d a
Ph
ase
Shift, is recorded
; and
the figure
is transla
ted to flow
.
Proven, Noninvasive Bioreactance TechnologyTh
e n
on
inva
siv
e C
he
eta
h N
ICO
M h
as b
ee
n p
rove
n to
be
faste
r an
d m
ore
ac
cu
rate
in c
om
pa
riso
n to
inva
siv
e te
ch
no
log
ies s
uc
h a
s th
e p
ulm
on
ary
arte
ry c
ath
ete
r an
d e
so
ph
ag
ea
l do
pp
ler.
Validated Bioreactance TechnologyA
uth
or
Jo
urn
al
Ye
ar
Title
Su
mm
ary
Kere
n, H e
t al
Am
J P
hysio
l
He
art C
i
2007Eva
luatio
n of a
noninva
sive c
ontinuo
us c
ard
iac
outp
ut mo
nitoring
system
ba
sed
o
n thora
cic
bio
rea
cta
nce
.
NIC
OM
hig
h C
O c
orre
latio
ns w
ith P
AC
(r=.9
0)
in 2
7 p
atie
nts
& tra
nso
nic
do
pp
ler in
9 a
nim
als
(r=.8
7)
Ma
rik PE, et a
lC
he
st2013
The use
of b
iore
ac
tanc
e a
nd c
aro
tid
Do
pp
ler to
de
term
ine vo
lume
re
spo
nsivene
ss and
blo
od
flow
re
distrib
ution fo
llow
ing p
assive
leg
raising
in he
mo
dyna
mic
ally unsta
ble
pa
tients
Bio
rea
cta
nc
e p
rovid
es a
n a
cc
ura
te m
eth
od
of
asse
ssin
g v
olu
me
resp
on
siv
en
ess in
critic
ally
ill
patients. Sensitivity 94%, specificity100%
. N= 34
Rava
l NY, e
t al/
J C
lin M
on
it
Co
mp
ut/
2008M
ultice
nter e
valua
tion o
f noninva
sive
ca
rdia
c o
utput m
ea
surem
ent b
y b
iore
ac
tanc
e te
chniq
ue
CO
me
asu
rem
en
ts m
ad
e s
imu
ltan
eo
usly
NIC
OM
& T
D in
CC
U, IC
U &
ca
rdia
c c
ath
ete
riza
tion
lab
s.
NIC
OM
resu
lts h
igh
ly c
orre
late
d w
ith T
D (r=
.78).
N=111
Rich JD
, et a
l Eu
r Re
spir
2013N
onivna
sive c
ard
iac
outp
ut m
ea
surem
ents in p
atie
nts with p
ulmo
nary
hype
rtensio
n
NIC
OM
pe
rform
ed
with
mo
re p
rec
isio
n th
an
Swan TD
in vasodilator challenge (p<0.001) & c
orre
late
d in
ac
cu
rac
y w
ith F
ick
in C
O. N
=20
Squa
ra, P e
t a
Inte
nsiv
e
Ca
re M
ed
2007N
oninva
sive c
ard
iac
outp
ut mo
nitoring
(N
ICO
M): a
clinic
al va
lida
tion
NIC
OM
had a 93% sensitivity and 93%
specificity fo
r de
tec
ting
dire
ctio
na
l ch
an
ge
s. N
ICO
M
co
rrela
ted
hig
hly
with
the
rmo
dilu
tion
(r=.8
2).
N=110
Squa
ra P, e
t al
Critic
al C
are
2009C
om
pa
rison o
f mo
nitoring
pe
rform
anc
e
of Bio
rea
cta
nce
vs. pulse
co
ntour d
uring
lung re
cruitm
ent m
ane
uvers
NIC
OM
& P
ICC
O h
ad
eq
uiv
ale
nt C
O &
SV
mo
nito
ring
ca
pa
bilitie
s, in
clu
din
g th
e a
bility
to
de
tec
t dire
ctio
na
l ch
an
ge
s in
CO
. N=
20
Wa
ldro
n NH
, et a
l A
SA
ab
strac
t
2013N
ICO
M ve
rsus EDM
guid
ed
go
al d
irec
ted
fluid
thera
py in the
pe
riop
era
tive p
erio
dC
onsistent & significant correlation of baseline SV
between m
onitors in 234 fluid challenges. N=61
Fluid Managem
ent Makes a Clinical Difference
Au
tho
rJo
urn
al
Ye
ar
Title
Su
mm
ary
Ma
rik PE, et a
l A
nn
als o
f
inte
nsiv
e
ca
re
2011H
em
od
ynam
ic p
ara
me
ters to
guid
e fluid
the
rap
yFo
r de
ca
de
s, th
e c
orn
ers
ton
e o
f trea
ting
pa
tien
ts
with shock has been intravenous fluids.
Pow
ell-Tuc
k J B
ritish
Me
dic
al
Jo
urn
al
2009Intra
veno
us fluids in a
dults und
erg
oing
surg
ery; British C
onse
nsus Guid
eline
s o
n Intrave
nous Fluid
Thera
py fo
r Ad
ult Surg
ica
l Patie
nts
Co
nc
ern
ha
s a
rise
n fro
m a
hig
h in
cid
en
ce
of
po
sto
pe
rativ
e s
od
ium
an
d w
ate
r ove
rloa
d.
Evidence suggests that more accurate fluid
the
rap
y w
ou
ld im
pro
ve
ou
tco
me
s.
Bioreactance vs. Bioimpedance
Au
tho
rJo
urn
al
Ye
ar
Title
Su
mm
ary
Leslie
SJ, et a
l B
loo
d P
ress
Mo
nit
2004N
on-inva
sive m
ea
surem
ent o
f card
iac
o
utput in p
atie
nts with chro
nic hea
rt failure
Th
ora
cic
bio
imp
ed
an
ce
sh
ow
ed
a p
oo
r leve
l of
ag
ree
me
nt w
ith th
erm
od
ilutio
n.
Jako
vljevic
DG
, e
t al
J C
lin M
on
it
Co
mp
ut
2012C
om
pa
rison o
f card
iac o
utput d
ete
rmine
d
by b
ioim
pe
da
nce a
nd b
iore
acta
nce
me
thod
s at re
st and
during
exe
rcise
In c
on
trast w
ith b
ioim
pe
da
nc
e, b
iore
ac
tan
ce
ca
rdia
c o
utp
uts
are
sim
ilar to
tho
se
estim
ate
d
from m
easured oxygen consumption. N
=12
The Cheetah NICOM
has been reported to:H
ave
a se
nsitivity o
f 94% a
nd
sp
ec
ificity o
f 100% fo
r pre
dic
ting
flu
id re
spo
nsive
ne
ss in c
ritica
l c
are
situa
tion
s 1
Pred
ict flu
id re
spo
nsive
ne
ss c
om
pa
rab
ly to e
sop
ha
ge
al
Do
pp
ler a
nd
oth
er in
vasive
m
od
alitie
s 2
Re
du
ce
ho
spita
l stays 3
Be c
ost-e
ffec
tive 4
Cheetah NICOM offers:
A p
orta
ble
an
d lig
htw
eig
ht (H
: 8.7”, W: 10.2”,
D: 7.9”, 6.6 lb
s) 8” tou
ch
scre
en
mo
nito
r
Setu
p w
izard
wh
ich
wa
lks the
clin
icia
n th
rou
gh
an
e
asy ste
p b
y step
pro
toc
ol fo
r exe
cu
ting
the
PLR te
st
First resu
lts in a
pp
roxim
ate
ly 70 sec
on
ds
Easy to
na
viga
te to
uc
h sc
ree
n
Mo
nitor fits o
n a ta
ble
or IV
po
le
Op
en
pla
tform
fac
ilitate
s co
nn
ec
tion
to EM
R
Batte
ry op
era
tion
Easy to Use ... Robust ... Flexible and, Of Course ... Noninvasive
Run ScreenR
ea
l time
, co
ntin
uo
us b
ea
t to
be
at d
ata
Disp
lays re
sults in
rea
l time
for
CI, H
R, N
IBP, SVI a
nd
SV
Trend DisplayD
ispla
ys pa
ram
ete
rs g
rap
hic
ally
Disp
lays g
rap
hic
ally re
sults
of a
ll save
d o
r on
go
ing
m
ea
sure
me
nts – SV
, SVI,
CO
, CI, H
R, N
IBP, (SBP, DH
P
& M
AP), TPR
I, TPR
1. M
arik
PE, e
t al, C
he
st, 2
013 2
. Ke
ren
, H e
t al, A
m J
Ph
ysio
l He
art C
i, 2007 3
,4. D
un
ha
m e
t al, J
Tra
um
a A
cu
te C
are
Su
rg. 2
012
CHEETAH
NICO
M
Numerical
DashboardD
ispla
ys pa
ram
ete
rs n
um
eric
ally
Disp
lays n
um
eric
ally a
ll save
d
or o
ng
oin
g m
ea
sure
me
nts –
CO
, CI, H
R, N
IBP, MA
P, TPRI,
TPR, SV
, SVI, SV
V
13
2
Gra
ph
ic re
pre
sen
tatio
n o
f ba
selin
e
vs. fluid
ch
alle
ng
e
Ind
ica
tes w
he
the
r the
pa
tien
t is
fluid
resp
on
sive
Me
asu
res re
spo
nse
ran
ge
, ba
selin
e th
rou
gh
ch
alle
ng
e fo
r CI, H
R, M
AP, TPR
I, SVI, D
O2I &
TFC1
23
CHEETAH
NICO
MW
HENEVER GOAL DIRECTED HEMODYNAM
IC THERAPY AND REAL TIM
E FEEDBACK ARE NEEDED.
No
ma
tter w
he
re th
e p
atie
nt is in
the
ho
spita
l, NIC
OM
rea
l time
da
ta e
na
ble
s e
fficie
nt u
se o
f the
clin
icia
n’s tim
e, im
pro
ves d
iag
no
stic p
rec
ision
an
d
fac
ilitate
s effe
ctive
he
mo
dyn
am
ic tre
atm
en
t.
Emergency Departm
ent (ED)
Freq
ue
ntly, th
e sta
ff ha
s no
histo
ry. The
pa
tien
t ma
y ha
ve su
ffere
d
seve
re tra
um
a a
nd
ma
y be
un
co
nsc
iou
s or in
co
he
ren
t. The
righ
t
clin
ica
l de
cisio
ns c
an
ma
ke th
e d
iffere
nc
e b
etw
ee
n life
an
d d
ea
th.
The
Ch
ee
tah
NIC
OM
lea
ds a
re e
asy to
ap
ply a
nd
ca
n “tra
vel” w
ith th
e
pa
tien
t. Ap
pro
xima
tely 70 se
co
nd
s afte
r the
lea
ds h
ave
be
en
ap
plie
d,
he
mo
dyn
am
ic d
ata
is ava
ilab
le.
No
mo
re w
aitin
g fo
r a te
ch
nic
ian
to a
rrive o
r a re
sult to
co
me
ba
ck in
a
critic
al situ
atio
n. ED
pe
rson
ne
l ca
n:
•
De
term
ine
wh
eth
er th
e p
atie
nt is flu
id re
spo
nsive
•
Evalu
ate
the
hyp
ote
nsive
pa
tien
t
•
Asse
ss ca
rdia
c fu
nc
tion
•
Dia
gn
ose
the
ca
use
of d
yspn
ea
•
An
d m
uc
h m
ore
Medical ICU (M
ICU)
With
the
ph
ysiolo
gic
al p
ara
me
ters c
on
tinu
ou
sly ava
ilab
le th
rou
gh
NIC
OM
, clin
icia
ns c
an
:
•
Asse
ss in re
al tim
e th
e re
spo
nse
to th
era
py, e
.g., flu
ids o
r pre
ssors
•
Ha
ve re
al tim
e in
form
atio
n a
vaila
ble
, for e
fficie
nt u
se o
f the
ir
time
. No
mo
re w
aitin
g fo
r a te
st, e.g
., an
ec
ho
ca
rdio
gra
m, to
be
pe
rform
ed
an
d th
e re
sults to
arrive
•
Evalu
ate
an
d tre
at w
ith c
on
fide
nc
e p
atie
nts w
ith C
HF, M
I or
ac
ute
isch
em
ia.
•
Ha
ve a
t the
ir fing
ertip
s the
critic
al in
form
atio
n n
ec
essa
ry to
ma
na
ge
seve
re se
psis a
nd
sep
tic sh
oc
k
Operating Room (OR)
The
an
esth
esio
log
ist an
d re
st of th
e su
rgic
al te
am
ca
n, in
rea
l time
:
•
Pay sp
ec
ial a
tten
tion
to th
e n
ee
ds o
f co
mp
rom
ised
pa
tien
ts, e.g
.,
ca
rdia
c p
atie
nts w
ith a
n e
jec
tion
frac
tion
< 25%
•
Trea
t pro
mp
tly to p
reve
nt a
n in
tero
pe
rative
crisis in
surg
ica
l
pro
ce
du
res w
ith h
igh
fluid
shifts, e
.g., ro
bo
tic p
rosta
tec
tom
y
•
Sup
po
rt go
al d
irec
ted
fluid
the
rap
y initia
tives
Surgical ICU (SICU)
Patie
nts o
ften
em
erg
e fro
m su
rge
ry with
an
ind
ete
rmin
ate
volu
me
statu
s du
e to
sign
ifica
nt flu
id sh
ifts intra
pro
ce
du
rally. A
n o
ptim
um
rec
ove
ry is fac
ilitate
d b
y esta
blish
ing
ad
eq
ua
te p
erfu
sion
as so
on
as
po
ssible
. NIC
OM
is esp
ec
ially u
sefu
l with
:
•
Frag
ile p
atie
nts, o
ften
eld
erly
•
Patie
nts w
ith fe
ver
•
Patie
nts w
ith se
psis ( SV
R , C
O )
•
Trau
ma
pa
tien
ts
Other Patient Settings in the Hospital
With
critic
al in
form
atio
n b
ein
g a
vaila
ble
ap
pro
xima
tely 70 se
co
nd
s
afte
r the
sen
sors a
re p
lac
ed
, the
po
rtab
le C
he
eta
h N
ICO
M is id
ea
l for
a ra
pid
resp
on
se to
an
em
erg
ing
crisis in
an
y pa
tien
t settin
g w
ithin
the
ho
spita
l.
Cheetah NICOMWhat do the users say?
“The NICOM has become invaluable in my everyday practice of emergency medicine. For the patient who
presents with hypotension, the NICOM helps differentiate the various categories of shock. Additionally, without the
NICOM, determining fluid responsiveness at the bedside is often difficult at best. For example, managing suspected
sepsis expertly in patients who are anephric and/or have impaired systolic function is almost medically impossible
without utilizing the NICOM passive leg raise maneuver to assess fluid responsiveness in real time.”
- Howard Dickey-White MD, University Emergency Specialists, Inc
“The beauty of using the NICOM in our institution is that it gave us the ability to protocolize resuscitation of
hemodynamically unstable patients. This enables nurses to conduct the resuscitation over time, automatically
adjusting care to patient response to the therapy. The physician does not have to be at the bedside continuously
but can be in more of a supervisory role, making sure the protocol is appropriate and safe for the individual patient.”
- Terry P. Clemmer, MD, Director of Critical Care Medicine, LDS Hospital, Salt Lake City, Utah
Cheetah NICOM is Versatile Compared to Alternative Modalities NICOM Pulse Contour Thermo Dilution
Severe vasoconstriction i.e. shock (septic, cardiogenic) 1 + − +
Arrythimia 1,2 + − + / −
Arterio-spasm 1 + − +
Pulmonary Hypertension 2 + + + / −
Noninvasive + − −
1. Edwards Life Sciences: http://www.edwards.com/products/mininvasive/Page/flotracfaqs.aspx 2. Rich Jonathan D, Archers SL, rich 5, Noninvasive cardiac output measurement in patients with pulmonary hypertension Eur Respr J 2013; 42; 125-133
Cheetah Medical, Inc.
600 SE Maritime Ave Suite 220
Vancouver, WA 98661 USA
Toll free: (+1) 866-751-9097
Tel: (+1) 360-828-8685
www.cheetah-medical.com
ORDERING INFORMATION
Product Description Code
Cheetah NICOM® Noninvasive Hemodynamic Management System, with 3.7m patient cable, USB cable, power cord, EMR software
CMM-RE4
Cheetah NICOM Sensor (25 Box), Pre-attached Leadwires CMS25
Cheetah NICOM Sensor (50 Box), Pre-attached Leadwires CMS50
FINANCING
Financing is available for the Cheetah NICOM. Please contact your
Cheetah Hemodynamic Sales Specialist for more information.
Cheetah Medical is a trademark of Cheetah Medical. Bioreactance and NICOM are registered trademarks of Cheetah Medical R-MRK-05 rev1 0913, 2500
